Peptide Electronic Batch Record Compliance: 21 CFR Part 11 Guide

Electronic batch records (EBRs) are replacing paper records in peptide manufacturing facilities around the world. They are faster, more accurate, and easier to review than paper.

But EBRs come with their own set of compliance requirements. If your electronic system does not meet FDA rules, you could face serious regulatory problems.

What Are Electronic Batch Records?

An electronic batch record is a digital version of the traditional paper batch record. It captures all the data from a manufacturing batch in an electronic system.

EBRs record who did what, when they did it, what materials were used, and what results were obtained. They replace handwritten entries with electronic data capture.

For peptide manufacturing, EBRs can track every step of synthesis, purification, lyophilization, and packaging. They provide real-time visibility into your production process.

Why Switch to Electronic Batch Records?

There are many good reasons to move from paper to electronic records.

Benefit	Explanation
Fewer Errors	System enforces correct data entry and prevents missing fields
Faster Review	Automated checks reduce review time by 50-70%
Better Traceability	Automatic audit trails capture every action
Real-Time Visibility	Managers can monitor production in real time
Easier Retrieval	Find any record in seconds instead of hours
Space Savings	No more filing cabinets full of paper records

According to research published by the International Society for Pharmaceutical Engineering (ISPE), companies that implement electronic batch records typically see a 30-50% reduction in batch record review time and a significant decrease in data entry errors compared to paper-based systems.

21 CFR Part 11: The Key Regulation

The most important regulation for EBRs is 21 CFR Part 11. This FDA rule sets the requirements for electronic records and electronic signatures.

Part 11 was issued in 1997 and has been the foundation for electronic records compliance ever since. The FDA also published guidance documents in 2003 that clarify how the rule should be applied.

Key Part 11 Requirements

Part 11 has two main parts: requirements for electronic records and requirements for electronic signatures.

Electronic Record Requirements

• Validation: The system must be validated to ensure accuracy, reliability, and consistent intended performance
• Audit trails: The system must create a secure, computer-generated, time-stamped audit trail of all changes
• Record retention: Electronic records must be maintained for the required retention period
• System access: Limit access to authorized individuals
• Authority checks: Only people with the right permissions can perform specific actions
• Device checks: Verify the source of data input
• Operational controls: Written procedures for system use and maintenance
• Personnel accountability: Each person has a unique account

Electronic Signature Requirements

• E-signatures must be unique to one person
• E-signatures must not be reused or reassigned
• Before using e-signatures, the company must certify to the FDA
• E-signatures must include the printed name, date, time, and meaning of the signature
• E-signatures must be linked to their electronic records so they cannot be copied or transferred

"Part 11 compliance is not about buying the right software. It is about how you configure, validate, and use the system. I have seen expensive systems fail audits because they were not properly set up," warns Dr. Steven Park, a computer system validation expert who has helped implement EBR systems at over 30 pharmaceutical companies.

Implementing EBRs in a Peptide Facility

Moving from paper to electronic batch records is a big project. Here is how to approach it.

Step 1: Select the Right System

Choose an EBR system that meets your needs and is designed for pharmaceutical manufacturing. Look for systems that are Part 11 compliant out of the box.

Popular EBR systems include MasterControl, Veeva Vault, and Körber (formerly Werum) PAS-X. Evaluate each system against your specific peptide manufacturing requirements.

Step 2: Define Your Requirements

Before implementing, write a User Requirements Specification (URS). This document describes exactly what you need the system to do.

For peptide manufacturing, your requirements should cover peptide synthesis steps, in-process testing, material management, equipment integration, and batch disposition.

Step 3: Validate the System

Validation is required by Part 11. Follow the standard validation approach: Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ).

Include test cases for all critical functions, including data entry, calculations, electronic signatures, audit trails, and reporting.

Validation Stage	What You Test
IQ	Software installation, hardware configuration, network connectivity
OQ	All functions work as designed, security controls, audit trails
PQ	System performs correctly under real production conditions
Data Migration	Historical data transferred accurately (if applicable)

Step 4: Train Your Team

Train all users on the new system before go-live. Include training on system functions, data entry procedures, and Part 11 requirements.

Document all training and verify that each user can operate the system correctly before granting production access.

Step 5: Go Live

Start with a pilot batch to verify everything works in the real manufacturing environment. Monitor closely and address any issues immediately.

After a successful pilot, roll out the system to full production. Keep your paper backup process available during the transition period.

Audit Trail Requirements

The audit trail is one of the most critical features of an EBR system. It records every action taken on every record.

What the Audit Trail Must Capture

• Who performed the action (user ID)
• What was done (created, modified, deleted)
• When it was done (date and time stamp)
• Why it was done (reason for change)
• The old value and the new value (for modifications)

Audit Trail Review

You must review audit trails regularly. This is a key data integrity requirement.

Review audit trails as part of your batch record review process. Look for unusual patterns, unauthorized changes, or suspicious timing of entries.

For more on data integrity in peptide manufacturing, see our article on data integrity regulatory requirements.

Common Part 11 Compliance Gaps

Many EBR implementations have compliance gaps. Here are the most common ones.

• Audit trails not enabled for all fields
• Shared login accounts
• No procedure for managing user accounts (adding, removing, modifying)
• System not validated or validation out of date
• No periodic review of audit trails
• E-signature certification not filed with FDA
• No disaster recovery plan for the system
• Missing or incomplete SOPs for system use

Integration with Other Systems

EBR systems work best when they are integrated with other systems in your facility.

Common Integrations

• LIMS: Laboratory Information Management System for test results
• ERP: Enterprise Resource Planning for material management
• Equipment: Direct data capture from instruments
• SCADA: Process control data from manufacturing equipment
• eQMS: Quality management system for deviations and CAPAs

Integration reduces manual data entry, which reduces errors. It also provides a more complete picture of each batch.

Hybrid Systems

Some facilities use a hybrid approach, combining electronic and paper records. This is acceptable, but you need clear procedures for how the two systems work together.

If you have any paper elements in an otherwise electronic process, document how paper records are linked to the electronic batch record. Make sure data integrity is maintained for both types of records.

Cloud-Based EBR Systems

Cloud-based EBR systems are becoming more popular. They offer flexibility, scalability, and lower upfront costs.

However, cloud systems require extra attention to data security, data sovereignty, and vendor management. Make sure your cloud provider meets all Part 11 requirements.

Include the cloud provider in your validation and audit programs. You are still responsible for compliance, even if the system is hosted by a third party.

Cost Considerations

Implementing an EBR system requires a significant investment. Here are the main cost categories.

Cost Category	Typical Range
Software licenses	$100,000 to $500,000+
Implementation services	$200,000 to $1,000,000
Validation	$50,000 to $200,000
Training	$20,000 to $50,000
Annual maintenance	15-20% of license cost

The return on investment typically comes from reduced review time, fewer errors, and faster batch release. Most companies see a positive ROI within 2 to 3 years.

For more on staffing your implementation team, check out our workforce solutions for peptide companies.

Frequently Asked Questions

Do I need to file an e-signature certification with the FDA?

Yes. Before using electronic signatures as the legally binding equivalent of handwritten signatures, you must submit a certification to the FDA. This is a letter to your local FDA district office stating that your electronic signatures are intended to be the legally binding equivalent of traditional handwritten signatures.

Can I keep backup paper copies of my electronic batch records?

Yes, you can keep paper backups for disaster recovery purposes. However, the electronic record must be the primary record. If there is a discrepancy between the electronic and paper versions, the electronic record takes precedence.

How long must electronic batch records be retained?

Electronic batch records must be retained for the same period as paper records. For drug products, this is at least one year past the expiration date of the batch. Make sure your system can reliably store and retrieve records for the entire retention period.

What happens during an FDA inspection of an EBR system?

FDA inspectors will ask to see your validation documentation, audit trail reports, user access controls, and SOPs for system use. They may also ask to see specific batch records and walk through the system with you. Having a trained system administrator available during inspections is essential.

Can I use spreadsheets as electronic batch records?

Spreadsheets are generally not appropriate for use as electronic batch records because they lack built-in audit trails, access controls, and other Part 11 features. If you use spreadsheets for GMP data, they need additional controls and validation, which can be more complex than using a purpose-built EBR system.

What should I do if my EBR system goes down during production?

Have a documented procedure for system downtime. This should include switching to paper records, procedures for entering data into the system once it is back up, and verification steps to ensure no data is lost. Test your downtime procedures regularly.

Final Thoughts

Electronic batch records are the future of peptide manufacturing documentation. They improve accuracy, speed, and compliance when implemented correctly.

The key to success is proper planning, thorough validation, and ongoing compliance management. Do not rush the implementation. Take the time to do it right.

When your EBR system is running smoothly, you will wonder how you ever managed with paper. Your team will be more productive, your reviews will be faster, and your data will be more reliable.